Skip to Content

Notice

Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories

This document has a comment period that ends in 54 days. (08/12/2019) Submit a formal comment

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 12, 2019.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on March 14, 2019, Eli-Elsohly Laboratories, Mahmoud A. Elsohly Ph.D., 5 Industrial Park Drive, Oxford, Mississippi 38655 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substanceDrug codeSchedule
Marihuana Extract7350I
Marihuana7360I
Start Printed Page 27662
Tetrahydrocannabinols7370I
Dihydromorphine9145I
Amphetamine1100II
Methamphetamine1105II
Cocaine9041II
Codeine9050II
Dihydrocodeine9120II
Oxycodone9143II
Hydromorphone9150II
Ecgonine9180II
Hydrocodone9193II
Morphine9300II
Thebaine9333II
Oxymorphone9652II

The company plans to manufacture the listed controlled substances for product development and reference standards. In reference to drug codes 7360 (marihuana) and 7370 (THC), the company plans to isolate these controlled substances from procured 7350 (marihuana extract). In reference to drug code 7360, no cultivation activities are authorized for this registration. No other activities for these drug codes are authorized for this registration.

Start Signature

Dated: June 3, 2019.

John J. Martin,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-12505 Filed 6-12-19; 8:45 am]

BILLING CODE 4410-09-P